Analyst Recommendations

BMO Capital analyst issues MARKET PERFORM recommendation for XOM on October 4, 2024 08:40AM ET. The previous analyst recommendation was Market Perform.XOM was trading at $122.58 at issue...

October 4, 2024   XOM -0.51%

BMO Capital analyst issues OUTPERFORM recommendation for CVE on October 4, 2024 08:41AM ET. The previous analyst recommendation was Outperform.CVE was trading at $17.84 at issue of the...

October 4, 2024   CVE -1.33%

Jefferies analyst issues BUY recommendation for NEM on October 4, 2024 09:01AM ET. The previous analyst recommendation was Buy.NEM was trading at $53.04 at issue of the analyst...

October 4, 2024   NEM -6.23%

Jefferies analyst issues BUY recommendation for GOLD on October 4, 2024 09:01AM ET. The previous analyst recommendation was Buy.GOLD was trading at $19.85 at issue of the analyst...

October 4, 2024   NEM -6.23%

Janney Montgomery analyst issues BUY recommendation for CCJ on October 4, 2024 08:31AM ET. CCJ was trading at $49.96 at issue of the analyst recommendation.The overall analyst consensus...

October 4, 2024   CCJ 2.12%

Goldman Sachs analyst issues NEUTRAL recommendation for LYG on October 4, 2024 04:32AM ET. LYG was trading at $2.99 at issue of the analyst recommendation.The overall analyst consensus...

October 4, 2024   LYG 0.66%

Macquarie analyst issues NEUTRAL recommendation for LI on October 4, 2024 04:57AM ET. LI was trading at $28.82 at issue of the analyst recommendation.The overall analyst consensus :...

October 4, 2024   LI -1.39%

Barclays analyst issues OVERWEIGHT recommendation for DKNG on October 4, 2024 05:50AM ET. The previous analyst recommendation was Overweight.DKNG was trading at $38 at issue of the analyst...

October 4, 2024   DKNG -4.90%

Cowen & Co. analyst issues BUY recommendation for CVS on October 4, 2024 05:40AM ET. The previous analyst recommendation was Hold.CVS was trading at $62.92 at issue of...

October 4, 2024   CVS 1.06%

Morgan Stanley analyst issues BUY recommendation for MS on October 3, 2024 04:18PM ET. The previous analyst recommendation was Underperform.MS was trading at $104.57 at issue of the...

October 3, 2024   MS 2.86%